需要什么才能成功实施欧盟医疗卫生交易法规,使欧洲患者能够获得广泛的医疗保健服务?
Iga Lipska1, Francois Meyer2, Pier-Luigi Canonico3
1Health Policy Institute, Warsaw - Poland.
Global & regional health technology assessment
|January 21, 2025
概括
欧盟的卫生技术评估 (EU HTA) 条例需要政策重点超越技术细节. 专家建议建立信任,协作和利益相关方参与,以成功实施欧盟HTA.
科学领域:
- 卫生政策 卫生政策
- 卫生技术评估 卫生技术评估
- 欧盟的法规 欧盟的法规
背景情况:
- 关于即将出台的欧盟医疗技术评估 (EU HTA) 条例的政策实施和局限性的讨论有限.
- 主要关注的是欧盟HTA法规的技术方面.
研究的目的:
- 解决欧盟HTA法规的政策实施方面和潜在限制.
- 为有效实施欧盟HTA法规提出政策考虑.
主要方法:
- 召开了2024年5月在罗马召开的健康技术评估 (HTA) 专家会议.
- 促进了讨论,以确定和提出要考虑的关键政策要素.
主要成果:
- 在专家讨论中,出现了几项建议.
- 关键建议包括促进相互信任,加强合作,确保利益相关方全面参与.
- 重点是有效的沟通,各方公平的承诺和适当的激励结构.
结论:
- 欧盟HTA法规的成功实施需要一个强有力的政策驱动的方法.
- 建立信任,合作和利益相关者的参与对于导航政策格局至关重要.
- 欧盟的HTA法规应该在欧盟法律和政策发展的更广泛背景下看待.
相关概念视频
Legal Guidelines for Documentation
2.5K
The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:
2.5K
Standards of Care I
1.2K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.2K
Standards of Care II
1.1K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
Drug Control Governance: Regulatory Bodies and Their Impact
708
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
708
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
Drug Products: Biologics, Biosimilars and Interchangeables
370
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
370


